Latest Capital Raises News

Orbminco Limited reports promising interim infill drilling results at its Majestic North Gold Project, confirming high-grade shallow gold zones and potential southern extensions. The company also secures $5 million in a two-tranche placement to accelerate resource delineation and development.

Orpheus Uranium Limited has raised $4.36 million through a share placement anchored by IsoEnergy’s $1.5 million investment, aiming to accelerate uranium exploration across three Australian states.

Hot Chili Limited has raised A$40 million through a heavily oversubscribed private placement to accelerate the development of its La Verde copper-gold discovery within the Costa Fuego project in Chile. The funding will support expanded feasibility studies, environmental approvals, and further drilling aimed at defining a higher-grade starter pit.

Green & Gold Minerals Ltd (ASX, GG1) has announced the acquisition of the Burlington Silver-Copper project in Queensland’s Herberton Mineral Field, expanding its footprint in a region rich with future-facing metals essential for AI and electrification.

Botala Energy has raised A$3 million through an oversubscribed placement to fully fund drilling and flow testing at its Serowe coal bed methane project this quarter, advancing its commercial gas ambitions.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

PYC Therapeutics has successfully closed a $537 million institutional placement and entitlement offer, positioning the company to raise at least $600 million to advance its RNA-based therapies targeting genetic diseases.

Patagonia Lithium Ltd has successfully raised A$2.9 million through a private placement, aiming to fast-track drilling and feasibility studies at its flagship Formentera Project in Argentina.

Krakatoa Resources has raised $1.25 million through a well-supported placement to fund the next phase of exploration at its high-grade Zopkhito Antimony-Gold Project, following promising drilling results that validate historic data.

Island Pharmaceuticals has raised $9 million to advance its antiviral drug Galidesivir through the FDA’s Animal Rule pathway, targeting inclusion in the US Strategic National Stockpile for biodefense viruses.

Bellavista Resources has successfully raised A$35 million through a two-tranche placement to fund its strategic acquisition and exploration plans in Canada and Australia.

Strickland Metals has successfully raised A$55 million through an institutional placement to accelerate exploration and advance a Pre-Feasibility Study at its Rogozna Project in Serbia.